PresentationAlain MoussyCo-Founder, Chairman, President, CEO, MD & Scientific Director Good morning, and good afternoon for the participant to our web conference organized by AB Science. About an update of the clinical development of our asset called AB8939. My name is Alain Moussy, I'm the CEO of the company. And with me today, we have the presence of Nicholas Short, who is Professor at the MD Anderson and heading the Department of Leukemia; Olivier -- Professor Olivier Hermine, who has cofounded AB Scien ...